Richard G. Wunderink

Author

Also Known As

Benjamin D. Singer, Brad Spellberg, D. Mark Courtney, Gabriel Levy Hara, Hiwet Tzehaie, I. I. Siempos, Ignacio Martin-Loeches, Jacqueline M Kruser, Jacqueline M. Kruser, Joseph Paonessa

598

Publications

48.4K

Citations

H-Index

152

Concepts

All Affiliations

Northwestern University University of Tennessee Health Science Center Emory University Centers for Disease Control and Prevention Vanderbilt University

About

Richard G. Wunderink is an author at Northwestern University specializing in medicine, clinical microbiology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	49	81	11.7K
2	Health Sciences	13	14	3.4K
3	Nursing	2	2	42
4	Business	1	1	39
5	Engineering	1	1	43

Richard G. Wunderink

216

Publications

38.9K

Citations

H-Index

Page 1

	Year	Citations
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults Lionel A. Mandell, Richard G. Wunderink, Antonio Anzueto, Clinical Infectious Diseases	2007	6.2K
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults Seema Jain, Wesley H. Self, Richard G. Wunderink, New England Journal of Medicine	2015	3.3K
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children Seema Jain, Derek J. Williams, Sandra R. Arnold, New England Journal of Medicine	2015	1.8K
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia Antoní Torres, Michael S. Niederman, Jean Chastre, European Respiratory Journal	2017	1.3K
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP) Brian T. Tsuji, Jason M. Pogue, Alexandre Prehn Zavascki, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy Polymyxin Antibiotics ColistinSusceptibility TestingPharmacotherapyAntimicrobial ChemotherapyInfectious Diseases Pharmacists	2019	869
Angiotensin II for the Treatment of Vasodilatory Shock Ashish K. Khanna, Shane English, Xueyuan S. Wang, New England Journal of Medicine	2017	832
Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia Rogan A. Grant, Luisa Morales‐Nebreda, Nikolay S. Markov, Nature Adaptive Immune SystemImmunologyInfectious Respiratory DiseaseCellular Immune ResponseT Cells	2021	749
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial Matteo Bassetti, Roger Echols, Yuko Matsunaga, The Lancet Infectious Diseases Antimicrobial SusceptibilityHealth SciencesCarbapenem-resistant Gram-negative BacteriaKlebsiella PneumoniaeAntimicrobial Therapy	2020	732
Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. Edward Abraham, Antonio Anzueto, Guillermo Gutiérrez, PubMed	1998	628
Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Richard G. Wunderink, Jordi Rello, Sue Cammarata, PubMed	2003	565

Page 1